|
|||||
|
|
Docetaxel and Exisulind in Previously Treated Non-small Cell Lung Cancer (NSCLC) Patients: A Multicenter,Phase II Clinical Trial |
|
| Affiliation: | 2. University of Colorado Cancer Center, Aurora, Colorado;3. University of Chicago Medical Center, Chicago, Illinois;4. OSI Pharmaceuticals, Inc., Melville, New York |
| Abstract: | |
| Keywords: | Non-small cell lung cancer Exisulind Docetaxel Chemotherapy |
| 本文献已被 ScienceDirect 等数据库收录！ | |